3 CBD Penny Stocks on the Radar for April 2020

cbd penny stocks

The cannabis industry might have gone through some trouble in recent times, but the same can't be said for the CBD space. That's why it may be worthwhile for investors to have a look at some CBD penny stocks. The CBD market has grown at a remarkable pace in recent times, and it is expected to hold the momentum in the coming year.

According to estimates from leading consultancy firm Ernst & Young, the CBD industry in Canada could be worth $11 billion by 2025. In such a situation, many companies in the sector that are classified as penny stocks could go on to become major players in a fast-growing industry.

The change in the regulatory framework in 2019 (cannabis 2.0) was a massive boost to the industry. Companies involved in the CBD space are now able to manufacture and sell cannabis derivatives like edibles and beverages, among others. This may be the stimulus needed to get bigger investments in the CBD sector from established players.

Here are 3 CBD penny stocks that may be worth checking out:

3 CBD Penny Stocks on the Radar: Charlotte’s Web Holdings (TSX:CWEB) (OTCQX:CWBHF)

cbd penny stocks

Charlotte’s Web Holdings is the biggest CBD company in the United States, and although it has grown at a remarkable pace, there are some challenges that the company needs to tackle. Although CBD products are approved by the United States Food and Drugs Administration, the agency recently warned about the dangers of those products. While that could be considered a problem for companies like Charlotte's Web, there are other factors that make CWEB a promising stock.

First, the company’s products are available at as many as 11,000 retail outlets across the United States. The acquisition of Abacus Health Products last week will help to expand Charlotte's Web's footprint even further.

Charlotte's Web is in the process of expanding its production capacity by building a facility spanning 137,000 square feet in Colorado. This facility will increase output capacity 10 times. The company expects to have the facility ready by the end of 2020.

>> These 4 Pot Stocks Could Recover Fast After the Coronavirus Sell-Off

The company is not yet profitable, but it has a price to sales ratio of 4.77 at this point, which certainly isn't something to turn your nose up at. Its continued retail and capacity expansion also makes Charlotte's Web a company that has the potential to dominate the CBD industry.

3 CBD Penny Stocks on the Radar: HEXO Corp (TSX:HEXO) (NYSE:HEXO)

HEXO has been in quite a bit of trouble over the past weeks, and the current week did not start off well for the company. HEXO released its fiscal second-quarter results for 2020 on Monday. Revenue for the quarter stood at $12.1 million, which reflects a sequential rise of 17%. The company also managed to reduce its net losses to $213 million for the quarter from $260 million in the fiscal first quarter.

However, this didn't seem to translate well to the stock, as investors sold it off, causing it to slump by 27% on Monday. However, HEXO stock rebounded about 10% this morning.

The losses suffered by the company in the quarter are primarily due to two impairments charges totaling $179 million. HEXO produced 22,305 kilos of the product during the quarter, which is a significant improvement from the 16,107 kilos it produced in the previous quarter.

That being said, the average selling price was $3.11 per gram in the previous quarter, but in Q2, it fell to $2.49 per gram. Due to the chaos caused by the coronavirus pandemic, HEXO did not provide projections for the fiscal year or the ongoing quarter.

3 CBD Penny Stocks on the Radar: The Valens Company (TSXV:VLNS) (OTCQX:VLNCF)

cbd penny stocks

The Valens Company provides cannabis extraction services to some of the biggest cannabis companies in the industry. The company is looking to sell CBD products in high growth markets as well. As with Charlotte's Web, the hemp-based CBD boom could also come as a massive opportunity for Valens.

At this point, the company counts cannabis firms like HEXO, Organigram Holdings (TSX:OGI) (NASDAQ:OGI), and Tilray Inc (NASDAQ:TLRY) among its clients. Valens has long-term deals in place with these cannabis producers, suggesting that it has the necessary CBD stock in place to sustain its business.

Valens also has the opportunity of signing white label deals with retailers like BRNT and Shopper’s Drug Mart. In 2019, Valens boosted its extraction capacity to 425,000 kilos, which should be able to help the company in the long run. By the middle of this year, Valens aims to process 1 million kilos.

Keep an eye on these 3 CBD penny stocks in the coming month.

>> Read More Penny Stock News

Featured image: DepositPhotos © -Taurus-

Please See Disclaimer

If You Liked This Article Click To Share

Risks and Disclosure:

Information provided in this correspondence is intended solely for informational purposes and is obtained from sources believed to be reliable. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained on this website is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions made or suggested and the actual results.

All statements and opinions expressed are the opinions of the author and not of Potstocknews.com or its officers. The author is wholly responsible for the validity of all statements. Potstocknews.com was not involved in any aspect of the article preparation. The author was not paid by Market Jar Media Inc for this article. The author did not pay Potstocknews.com to publish or syndicate this article.

This article does not constitute as investment advice. Each reader is encouraged to consult with his or her individual financial advisor; any and all actions taken by a reader as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Potstocknews.com's terms of use and full legal disclaimer. This article is in no way a solicitation for investment. Potstocknews.com does not render general or specific investment advice. Any information on Potstocknews.com should not be considered a recommendation to buy or sell any security. Potstocknews.com does not endorse or recommend the business, products, services or securities of any company mentioned on Potstocknews.com.

Futures, stocks and options trading involves substantial risk of loss and is not suitable for every investor. The valuation of futures, stocks, and options may fluctuate, and, as a result, clients may lose more than their original investment and possibly their entire investment. Any content on this website should not be relied upon as advice or construed as providing recommendations of any kind. It is your responsibility to confirm and decide which trades to make. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Please see our full disclaimer here for additional details before making any investment decisions.